Gilead Sciences GILD NASDAQ:GILD

Biotech Volatile Stocks: DARA Biosciences Inc (NASDAQ:DARA), Concert Pharmaceuticals Inc (NASDAQ:CNCE), Prosensa Holding NV (NASDAQ:RNA), CytRx Corporation (NASDAQ:CYTR)

DARA Biosciences Inc (NASDAQ:DARA) on May 15 announced its support for Neuropathy Awareness Week which is being observed during the week of May 12, 2014 and sponsored in the U.S. by The Neuropathy Association (www.neuropathy.org). DARA Biosciences Inc (NASDAQ:DARA) stock performance was -26.61% in last session and finished the day at $1.60. Traded volume was 4.15million shares in the last session and the average volume … Continue reading Biotech Volatile Stocks: DARA Biosciences Inc (NASDAQ:DARA), Concert Pharmaceuticals Inc (NASDAQ:CNCE), Prosensa Holding NV (NASDAQ:RNA), CytRx Corporation (NASDAQ:CYTR)

Biotech Losers: PTC Therapeutics (NASDAQ:PTCT), Prosensa Holding (NASDAQ:RNA), Concert Pharmaceuticals Inc (NASDAQ:CNCE), Tetralogic Pharmaceuticals Corp (NASDAQ:TLOG), Agios Pharmaceuticals Inc (NASDAQ:AGIO)

One solution, developed by PTC Therapeutics Inc. (NASDAQ:PTCT), a US biotechnology company, is to intervene in the transcription process in which the DNA is converted first to messenger RNA and then into protein. PTC Therapeutics Inc. (NASDAQ:PTCT)’s experimental drug ataluren is designed to override the false stop signal by interacting with the ribosome – the tiny biological machine inside every cell that runs along messenger … Continue reading Biotech Losers: PTC Therapeutics (NASDAQ:PTCT), Prosensa Holding (NASDAQ:RNA), Concert Pharmaceuticals Inc (NASDAQ:CNCE), Tetralogic Pharmaceuticals Corp (NASDAQ:TLOG), Agios Pharmaceuticals Inc (NASDAQ:AGIO)

Healthcare Losers: Cara Therapeutics (NASDAQ:CARA), ERBA Diagnostics Inc (NYSEMKT:ERB), Actinium Pharmaceuticals Inc (NYSEMKT:ATNM), Concert Pharmaceuticals (NASDAQ:CNCE)

Cara Therapeutics Inc (NASDAQ:CARA) — which has a preclinical cannabis compound — jumped 11.58%. The company is clearly running (smoke) rings around the competition and has the most appropriately named spokeswoman on Earth should it wish to employ the English supermodel as a mouthpiece. Cara Therapeutics Inc (NASDAQ:CARA) stock performance was -7.49% in last session and finished the day at $14.20. Traded volume was 123,773.00million … Continue reading Healthcare Losers: Cara Therapeutics (NASDAQ:CARA), ERBA Diagnostics Inc (NYSEMKT:ERB), Actinium Pharmaceuticals Inc (NYSEMKT:ATNM), Concert Pharmaceuticals (NASDAQ:CNCE)